Venmax Drugs and Pharmaceuticals has informed that a meeting of Board of Directors of the Company is proposed to be held on November 14, 2016, to consider and take note of the Unaudited financial results for the quarter ended September 30, 2016; and to review the working of the Company.
The above information is a part of company’s filings submitted to BSE.